奧園集團未按時披露2022年中期及年度報告 被上交所譴責
奧園集團未按時揭露2022年中期報告和年度報告,被指違反《證券法》和《公司信用類債券資訊揭露管理辦法》等相關規定,公司及其相關責任人被上海證券交易所公開譴責。
根據上交所的譴責決定,奧園集團時任董事長郭梓寧、時任執行董事、總經理林顯團以及時任財務負責人、資訊揭露事務負責人陳志斌,因未能勤勉盡責,保證公司合規、及時履行資訊揭露義務,對違規行爲負有主要責任。
奧園集團及相關當事人對上述處分結果並無異議,並對因此造成投資人的不便深表歉意。同時,奧園集團表示將盡快完成2022年中期報告和年度報告的披露工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.